Sinphar Pharmaceutical Co.,Ltd.

Research Sinphar Pharmaceutical Co.,Ltd. (1734.TW) on Bullrun: market cap TWD 6.68B, P/E 19.1, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 6.68B; P/E is 19.1; dividend yield is 3.0%.

Peer valuation comparison

Latest P/E is 19.05x versus a Healthcare sector median of 21.74x (12.4% below).

Latest dividend yield is 3.02% versus a Healthcare sector median of 2.4% (25.8% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 6.68B19.13.0%0.94

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.94 TWD, yield 3.0%.

About Sinphar Pharmaceutical Co.,Ltd.

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO) TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)

Frequently asked questions

What is Sinphar Pharmaceutical Co.,Ltd.'s market cap?

Sinphar Pharmaceutical Co.,Ltd.'s market capitalization is TWD 6.68B.

What is Sinphar Pharmaceutical Co.,Ltd.'s P/E ratio?

Sinphar Pharmaceutical Co.,Ltd.'s price-to-earnings (P/E) ratio is 19.1.

Does Sinphar Pharmaceutical Co.,Ltd. pay a dividend?

Sinphar Pharmaceutical Co.,Ltd. has a dividend yield of 3.0%.

What does Sinphar Pharmaceutical Co.,Ltd. do?

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others.